Avtor/Urednik | Urlep-Šalinovič, Veronika; Jelatancev, Biserka; Lokar, Lidija; Zagradišnik, Boris; Kokalj-Vokač, Nadja | |
Naslov | Prirojeni trombofilični dejavniki pri bolnikih z vensko tromboembolijo | |
Prevedeni naslov | Hereditary thrombophilic factors in patients with venous thromboembolism | |
Tip | članek | |
Vir | Med Razgl | |
Vol. in št. | Letnik 39, št. Suppl 5 | |
Leto izdaje | 2000 | |
Obseg | str. 43-6 | |
Jezik | slo | |
Abstrakt | Venous thromboembolisms (VTE) are common cause of morbidity and death even in young patients. In most cases one or more hereditary and acquired factors are present. The most common hereditary factors are: activated protein C resistance (APCR), factor V Leiden (F V Leiden), polymorphism of prothrombin (A20210G), protein S (PS), protein C (PC) and antithrombin III (AT III) deficiency. In our study the hereditary thrombophilic factors in 95 patients with VTE were analized. In 55 (59.7%) patients one or more hereditary thrombophilic factors were detected. The most common F V Leiden was found in 15 (15.8%) patients in 12 patients (12.6%) two or three hereditary thrombophilic factors were found. The detection of thrombophilic faetors is important in thromboprophilaxis and anticoagulant therapy. | |
Izvleček | Venske tromboembolije (VTE) so pogosto vzrok obolevnosti in celo smrti tudi pri mlajših bolnikih. V večini primerov je prisoten eden ali več dednih in pridobljenih trombofiličnih dejavnikov. Najpogostejši dedni dejavniki so odpornost na aktivirani protein C (APCR), dejavnik F V Leiden (F V Leiden), polimorfizem za protrombin (A20210G), pomanjkanje proteina S (PS), protein C (PC) in antitrombina III (AT III). V naši študiji smo analizirali prirojene trombofilične dejavnike pri 95 bolnikih z VTE. Pri 45 (47,3 %) bolnikih smo dokazali prisotnost enega ali več prirojenih trombofiličnih dejavnikov. Najpogostejši je F V Leiden, ki smo ga našli pri skupno 11 (11,5%) bolnikih, pri 12 (12,6%) bolnikih smo našli dva oziroma tri trombofilične dejavnike. Odkrivanje trombofiličnih dejavnikov je pomembno za ustrezno tromboprofilakso in antikoagulantno zdravljenja. | |
Deskriptorji | THROMBOPHLEBITIS BLOOD COAGULATION DISORDERS PROTEIN C |